Skip to content

Dr. avennet

Active Private limited companyfounded 2019active for 7 yearsPopulierstraat 196, 8800 RoeselareKBO/BCE: BE 0720.802.743

Lifetime

7 annual accounts with figures on one time axis
peak of €224,615 in 2024
€200,996▼ 10.5%
lowest -€940 in 2019
€120,063▼ 13.1%
peak of €73,957 in 2021
€22,504▲ 0.3%
€192,948▼ 21.5%
Board2 names since 2019
2 directors and 1 other
Documentsfilings and deeds
22-06-202639 days before the deadline
2025micro format
Dividend €120,000Debts from €245,689 to €192,948Cash from €87,787 to €37,904

Key points

from the 2025 annual accounts

Equity

€22,504 from €73,957 in 2021

Equity fell by 70% in 4 years.

Turnover

≈ €360,000 estimated

The micro format states no turnover.

Debts

€192,948 90% of the balance sheet
Financial debts 9%Suppliers 0%Taxes and wages 17%Other 74%

Of this, €184,940 falls due within a year.

Filings

7 annual accounts 1 late
AprilJune31 JulyOctober202020222024

The 2019 accounts came 3 days late. The other six were filed on time.

Position in the sector

10.4%

Lower solvency than 85% of companies in human health. The sector median is 63.0%, over 21,385 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 6,715 companies had the same profile as Dr. avennet has now. Each dot stands for 17 companies, two years later.

95.8%
were still trading
2.2%
stopped another way
1.8%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more

Another 0.2% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,715 companies, not a prediction for Dr. avennet. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
Director
  • 186 sharesdeed of 19-02-2019
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0720802743
changes role from manager to director “De uitoefening van de genees, heel- en verloskunde en meer specifiek de huisartsengeneeskunde, in naam en voor…” (deed in Dutch) · General meeting of 06-12-2023 · Gazette deed
Incorporation Founding capital of €18,600, 186 shares, €12,400 paid up · Founded by · appointed as manager · published on 19-02-2019 · Gazette deed
First establishment Populierstraat 196, Roeselare
All 14 events

Comparable companies

same main activity, similar in size and age
Company
Dr. avennet Roeselare €215,452 €200,996 10.4% -
DR JAN LEZY Menen €239,844 €188,333 68.2% -
Dr. Tuur Helsen Leuven €227,022 €197,968 0.4% -
Lederer-Veevaete-Med Walhain €222,526 €214,918 68.9% -
Dr. Maes Lotte Vosselaar €202,396 €188,258 0.8% -
MEDISCH CENTRUM OOST Malle €222,620 €184,141 6.3% 2.8
Dokter Marie Smets Vosselaar €187,391 €196,827 93.4% -

These companies have the same main activity as Dr. avennet: general medical practice (NACE 86210). They are comparable in size and age: total assets between €187,000 and €240,000, founded between 2018 and 2020.

Official details

Source: KBO
Status
Active since 15-02-2019Normal situation
Activity
General medical practiceNACE 86210and 1 other
Establishment unit
2.285.383.1488800 Roeselare, since 15-02-2019
Financial year end
31 December
Peppol
Reachable since 20-12-2025
Company details

Annual accounts 2025

€215,452▼ 19.6%
Filing
Filed on 22-06-2026, 39 days before the end of the filing period
Financials

Insights on Dr. avennet

Dr. avennet files the micro format. That format states no turnover. The gross margin rose from €36,405 in 2019 to €200,996 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. avennet

What is the company number of Dr. avennet?
The company number of Dr. avennet is 0720.802.743. The VAT number is the same number with BE in front: BE 0720.802.743.
Where is Dr. avennet based?
The registered office is at Populierstraat 196, 8800 Roeselare.Company details
What does Dr. avennet do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. avennet?
Dr. avennet is a private limited company (BV).
When was Dr. avennet founded?
Dr. avennet was founded on 15-02-2019.
Is Dr. avennet still active?
Yes, Dr. avennet is an active enterprise in the KBO register.
What is the turnover of Dr. avennet?
The turnover in financial year 2025 is about €360,000. This figure is estimated from the gross margin of €200,996 and 30 comparable companies (NACE 86210). It probably lies between €290,000 and €460,000.Financials
Is Dr. avennet profitable?
In financial year 2025, Dr. avennet made a profit of €120,063.
Where can I find the annual accounts of Dr. avennet?
Dr. avennet filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. avennet due?
Dr. avennet must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.